Clinical Trial

Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated September 12, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
To investigate whether multiparametric MRI (mp-MRI) in patients with low-risk prostate cancer can improve the selection of patients suitable for Active Surveillance and have a relevance in the ongoing monitoring
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2018-08-24; most recent amendment 2025-09-08.
Status change: Not Yet Recruiting → Enrolling by Invitation 2020-11-12
Trial Details
NCT Number NCT03648359
Lead Sponsor Herlev Hospital
Conditions Prostatic Neoplasms
Enrollment 200 participants
Start Date 2020-05-01
Primary Completion 2026-01 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-12